EDE, Viatris sign MoU to strengthen local pharmaceutical manufacturing
Detailed summary
The MoU was signed by Dr. Fatima Al Kaabi, Director-General of the Emirates Drug Establishment, and Dr. Tamer Elsallab, Head of GCC and Levant Cluster at Viatris.
The Emirates Drug Establishment (EDE) has signed a memorandum of understanding (MoU) with Viatris, a global healthcare company, in a strategic move to boost investment opportunities and localise pharmaceutical manufacturing in the UAE. The agreement seeks to expand partnerships with international companies and leverage their expertise and advanced technologies alongside national capabilities, increasing the pharmaceutical sector’s added value and competitiveness while strengthening the UAE’s position as a regional and international hub for advanced pharmaceutical manufacturing and life sciences.
The MoU was signed by Dr. Fatima Al Kaabi, Director-General of the Emirates Drug Establishment, and Dr. Tamer Elsallab, Head of GCC and Levant Cluster at Viatris.
Areas of cooperation include developing local manufacturing capabilities, strengthening supply chain resilience, fostering Emirati talent through training initiatives, knowledge and expertise exchange, and professional development opportunities, alongside supporting pharmaceutical and healthcare innovation.
Dr. Al Kaabi affirmed that the UAE has established an integrated environment for investment in the pharmaceutical sector, combining an advanced regulatory framework, logistics infrastructure, research and development capabilities, and a strategic location. This enables international companies to build a long-term presence in the UAE, expand into regional markets and benefit from the country’s competitive advantages to grow their businesses.
She added, “Our partnership with Viatris reflects the Emirates Drug Establishment’s commitment to establishing a model for international partnerships that transforms cooperation with global companies into long-term industrial and knowledge-based projects within the UAE. We are working to expand this model to attract high-value investments and develop joint projects with national manufacturers, further strengthening the UAE’s position in global pharmaceutical value chains.”
Dr.…
The…
Opening of the article, excerpted from Zawya. To read the rest, open the article on the publisher's site.
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.zawya.com)
